INTERPACE BIOSCIENCES, INC. Net Income Loss

Quick Answer

INTERPACE BIOSCIENCES, INC. reported Net Income Loss of $24.58 million for the year ending 2025.

  • INTERPACE BIOSCIENCES, INC. showed an increase of +266.7% in Net Income Loss from 2024 to 2025.
  • This data is from INTERPACE BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q3 2016: -$7.49 million | Q1 2017: $2.41 million | Q2 2017: -$6.31 million | Q3 2017: -$3.32 million | Q1 2018: -$3.19 million | Q2 2018: -$1.92 million | Q3 2018: -$3.04 million | Q4 2018: -$4.04 million | Q1 2019: -$3.33 million | Q2 2019: -$5.30 million | Q3 2019: -$7.45 million | Q4 2019: -$10.66 million | Q1 2020: -$6.49 million | Q2 2020: -$5.58 million | Q3 2020: -$6.23 million | Q4 2020: -$8.14 million | Q1 2021: -$4.21 million | Q2 2021: -$3.45 million | Q3 2021: -$3.56 million | Q1 2022: -$2.25 million | Q2 2022: -$3.94 million | Q3 2022: -$14.21 million | Q1 2023: $514.0 thousand | Q2 2023: $559.0 thousand | Q3 2023: -$186.0 thousand | Q1 2024: $708.0 thousand | Q2 2024: $2.44 million | Q3 2024: $1.68 million | Q1 2025: $1.65 million | Q2 2025: -$640.0 thousand | Q3 2025: $911.0 thousand.
  • Over the full 16 years of available data (2010 to 2025), INTERPACE BIOSCIENCES, INC.'s Net Income Loss has grown by 460.7%.
  • Historical annual values: Fiscal year 2025: $24.58 million | Fiscal year 2024: $6.70 million | Fiscal year 2023: $1.95 million | Fiscal year 2022: -$21.96 million | Fiscal year 2021: -$14.94 million | Fiscal year 2020: -$26.45 million | Fiscal year 2019: -$26.74 million | Fiscal year 2018: -$12.19 million | Fiscal year 2017: -$12.22 million | Fiscal year 2016: -$8.33 million | Fiscal year 2015: -$11.36 million | Fiscal year 2014: -$16.07 million | Fiscal year 2013: -$4.57 million | Fiscal year 2012: -$25.53 million | Fiscal year 2011: -$11.91 million | Fiscal year 2010: -$6.81 million.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: